Long QT syndrome: genetics and future perspective E Wallace, L Howard, M Liu, T O’Brien, D Ward, S Shen, T Prendiville Pediatric cardiology 40, 1419-1430, 2019 | 134 | 2019 |
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus DA Domingo-Lopez, G Lattanzi, LHJ Schreiber, EJ Wallace, R Wylie, ... Advanced Drug Delivery Reviews 185, 114280, 2022 | 52 | 2022 |
The foreign body response to an implantable therapeutic reservoir in a diabetic rodent model R Beatty, CE Lu, J Marzi, RE Levey, D Carvajal Berrio, G Lattanzi, R Wylie, ... Tissue Engineering Part C: Methods 27 (10), 515-528, 2021 | 11 | 2021 |
Clinical utility of serum and urine soluble tnfr-1 and tnfr-2 in diabetic kidney disease TP Griffin, MN Islam, E Wallace, PM O'Shea, T O'Brien, MD Griffin Irish Journal of Medical Science 186, S367-S367, 2017 | 1 | 2017 |
SO018 SERUM AND URINE SOLUBLE TNFR-1 AND TNFR-2 DIFFERENTIALLY CORRELATE WITH EGFR AND ALBUMINURIA IN DIABETIC KIDNEY DISEASE MN Islam, T Griffin, E Wallace, P O'Shea, T O'Brien, M Griffin Nephrology Dialysis Transplantation 32 (suppl_3), iii10-iii11, 2017 | 1 | 2017 |
Exploring therapy transport from implantable medical devices using experimentally informed computational methods L Trask, NA Ward, R Tarpey, R Beatty, E Wallace, J O'Dwyer, W Ronan, ... Biomaterials Science, 2024 | | 2024 |
CONTROLLED DELIVERY OF VEGF USING AN IMPLANTABLE HYDROGEL LOADED SOFT ROBOTIC DRUG DELIVERY SYSTEM TO PREVASCULARISE AN IMPLANT SITE FOR ISLET TRANSPLANTATION E Wallace, S Straino, F Cianfarani, G Ciotti, T Mitra, L Schreiber, ... DIABETES TECHNOLOGY & THERAPEUTICS 24, A109-A109, 2022 | | 2022 |